Before and After: Attitude and Adverse Effects Induced by the First and Second Doses of mRNA BNT162b2 Vaccine among Healthcare Professionals in the First Weeks after Their Introduction in Poland

Background: In the last days of December 2020, the SARS-CoV-2 virus vaccine BNT162b2 (Comirnaty, Pfizer-BioNTech) was introduced, for the first time, for wide use in Poland. According to the vaccination schedule, healthcare workers were the first to receive the vaccine. The aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasternak, Gerard, Pieniawska-Śmiech, Karolina, Walkowiak, Mateusz, Sado, Joanna, Pytel, Adam, Jasińska, Paulina, Kierbiedź-Guzik, Natalia, Bolaczek, Paula, Fleischer-Stępniewska, Katarzyna, Babicki, Mateusz, Pentoś, Katarzyna, Lewandowicz-Uszyńska, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222834/
https://www.ncbi.nlm.nih.gov/pubmed/37242987
http://dx.doi.org/10.3390/vaccines11050883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222834/
https://www.ncbi.nlm.nih.gov/pubmed/37242987
http://dx.doi.org/10.3390/vaccines11050883

Ejemplares similares